Clinical Trial Update: DEnosumab for the Treatment of FIbrous Dysplasia/McCune-Albright Syndrome in Adults (DeFiD) [Phase 4]

View source ↗

Summary

The update indicates that the DeFiD Phase 4 trial of denosumab for fibrous dysplasia and McCune-Albright syndrome in adults is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibrous Dysplasia
• Mccune-albright Syndrome

Drugs mentioned

• Denosumab (denosumab)

Snippet

Sponsor: Natasha Appelman-Dijkstra | Conditions: Fibrous Dysplasia, McCune Albright Syndrome | Phase 4 | Status: RECRUITING